HN2
new
|
past
|
comments
|
ask
|
show
|
jobs
|
submit
login
Genetic Targets, Financial Creativity: BridgeBio's Model for Drug Development
(
sciencedirect.com
)
2 points
by
randycupertino
25 days ago
|
hide
|
past
|
favorite
|
1 comment
randycupertino
25 days ago
[–]
Interesting look at BridgeBio's spoke and hub drug development model, using genetically validated targets, rNPV (risk-adjusted value) and PoTS (probability of success) to set go/no-go decisions.
Guidelines
|
FAQ
|
Lists
|
API
|
Security
|
Legal
|
Apply to YC
|
Contact
Search: